...Aleve Market Plan XXXXXXXXX BUS 620 Managerial Marketing XXXXXXXXX xxxxxx Aleve Market Plan * Executive Summary of Marketing Plan Aleve All day strong. All day long Bayer Consumer Care manufactures parent company Bayer's line of over-the-counter drugs and nutritional supplements. One of the largest manufacturers of OTC drugs in the world, the division has production facilities in Europe, North America, Latin America, and Asia and sells its products in over 100 countries at pharmacies and other retail outlets (Law, Bayer AG, 2012). This market plan is to establish how Bayer Consumer Care, the manufacturers of Aleve intend to capitalize on the nonsteroidal anti-inflammatory drugs (NSAIDs) market as drugmakers scramble to grab Vioxx's and Bextra’s multi-billion-dollar share of the arthritis and pain-relief market. Aleve is used to treat pain or inflammation caused by conditions such as arthritis, ankylosing spondylitis, tendinitis, bursitis, gout, or menstrual cramps (Cerner Multum, Inc., 1996-2012). * Company Overview Take two Aspirin ... and maybe some Alka-Seltzer antacid and One-a-Day vitamins to be on the safe side. Bayer Consumer Care manufactures parent company Bayer's line of over-the-counter drugs and nutritional supplements. Its products include analgesics, cough and cold medicines, dermatology care, and gastrointestinal remedies. One of the largest manufacturers of OTC drugs in the world, the division has production facilities in Europe, North...
Words: 1771 - Pages: 8
...Strategic Analysis of Syngenta Jolly was a young, bright girl, studying her Bachelor of Business Administration. When she came home from college, her mind was occupied by the assignment given to her in her Business Strategy Class. She had to pick up a company of her choice and complete strategic analysis, over a period of three years, consisting of size of the organization, financial performance, operational performance, some tailored measures of performance relating to the organization’s industry, competitor analysis, strategic actions of the organization, and strategic issues faced. She thought that she would figure out what procedure to follow from her prescribed textbook ‘Strategic Management – Theory and Application,’ by Adrian Haberberg & Alison Rieple. After a certain thought, she chose Syngenta – headquartered at Basel, Switzerland. Jolly referred to the textbook and jotted down the procedure as below. Procedure for doing the Strategic Analysis: 1) Evaluate financial performance: Calculate the following quantities and analyze them and find out the trend in the last three years. Overall Sales Overall Profit Profitability ratios such as Return on Equity (ROE), Return on Assets (ROA), and Return on Capital Employed(ROCE). 2) Measure operational performance: Page 1 of 29 Calculate the following quantities; find out the trend and analyze: Operating profit Operating profit as a percentage of sales (profit margin) Sales per employee Operating profit per employee ...
Words: 6884 - Pages: 28
...complementary businesses within the group? What are the main group's competitors? Which main risks (that are inherent to this business sector) does the company mention? Which hedging policies are put in place? Profitability Which indicators have been brought forward in the annual report of the company? Which specific targets are aimed at? How does the group state and assess the evolution of profitability in the annual report? Is there more recent public information about this issue? Where? Is this information in line with the one mentioned in the annual report? Is it indicating a similar evolution? What are the main propositions of the company to improve its profitability? Financing What is the global financing strategy of the group? What is the evolution of the financing cost (several indicators)? What is the shareholders’ remuneration program? What are your sources (of information) regarding this issue? Investments What are the main investment / disinvestment policies? How are these investments financed? What is the outlook of the company regarding this issue? Consolidation process What are the most important consolidated subsidiaries? (Eventually mention the approximate number of subsidiaries)? Are there associated companies? What is the evolution of the income attributable to shareholders (or result part of the group)? What are the comments of the company regarding this...
Words: 9147 - Pages: 37
...Ming Zhi: 5515543 Group members: Chang Zhang: 5979309 Ming Zhi: 5515543 Lu Cao: 5949139 Ya Lei Qiang: 4119832 Xuechen Wang: 6443412 Table of content 1. Background information 3 1.1 Bayer 3 1.2 Johnson & Johnson 4 2. Vertical and horizontal analysis 5 2.1 Bayer’s Horizontal Analysis of the Income Statement 5 2.2 Johnson & Johnson 10 3. Ratio analysis 15 3.1 Profitability 15 3.2 Liquidity ratios 16 3.3 Efficiency 17 3.4 Gearing 18 3.5 Investment 19 4. Recommend and explain which company is more attractive to invest in 20 4.1 Profitability 20 4.2 liquidity position 21 4.3 turnover rate 21 4.4 leverage 22 4.5 earning for shareholders 22 4.6 Market prediction and analysts’ view 22 4.7 conclusions 23 5. Limitations of ratio analysis 23 1. Background information 1.1 Bayer Bayer is a German chemical and pharmaceutical company which is founded in Barmen Germany in 1863. At present, Bayer is a global enterprise with major business domains ishealth care, agriculture and high tech polymer materials. Bayer AG, Leverkusen, Germany, acts as a strategic management holding company. It shoulders whole company’s values, goals and strategies. It is also responsible for resource allocation and managerial appointments (Bayer 2014). Led by Bayer AG, the HealthCare, CropScience and MaterialScience subgroups independently manage their business operations in line with preset objectives. Main source of revenue: Segmented by geography (€ million) ...
Words: 6320 - Pages: 26
...Siemens Corporate Strategies: A Siemens AG Case Study Jeff Head Loyola University Chicago Foundations of Organization CPST 250 Dr. Marilyn Stocker February 13, 2015 Siemens AG, An Organizational Analysis “Siemens is a global technologies company comprised of 343,000 employees worldwide” (Karczewski, 2014). For the purpose of this paper an analysis of the company will be presented, to include a look at the company mission, human resources, markets, products offered, recent financial performance, and how engineering plays a major role in Siemens AG. Description of the Organization In 2013, Peter Loscher was replaced as CEO of Siemens AG by the current CEO Joe Kaeser. The following year Kaeser presented “Vision 2020”, a comprehensive plan to get the company back on track. This vision provided focus on the company’s path, positioning, culture and strategy. The strategic framework to support the vision centered on the company with four contributing elements: Customer and Business Focus, Governance, Management Model and Ownership Culture. Siemens History and Operations “Siemens was first founded in 1887 and started to expand with mass production and established a branch in Saint Petersburg and London for Russian lines and English lines” (Choudhary, 2013). It increased its production and started producing electrical power, lighting, and other advances after the Industrial Revolution, which enabled it to gain strength. After the end of World War II, it faced expropriation of over...
Words: 3176 - Pages: 13
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be an indepth discussion...
Words: 5468 - Pages: 22
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be...
Words: 5468 - Pages: 22
...Kellogg Graduate School of Management Northwestern University Evanston, IL 60208, USA p-kotler@kellogg.northwestern.edu Professor Waldemar Pfoertsch China Europe International Business School 699 Hongfeng Rd. Shanghai 201206, China wap@ceibs.edu e-ISBN 978-3-642-04214-0 ISBN 978-3-642-04213-3 DOI 10.1007/978-3-642-04214-0 Springer Heidelberg Dordrecht London New York Library of Congress Control Number: 2010926489 © Springer-Verlag Berlin Heidelberg 2010 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the German Copyright Law of September 9, 1965, in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the German Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Cover design: WMXDesign GmbH, Germany Printed on acid-free paper Springer is part of Springer Science+Business Media (www.springer.com) Foreword by Bayer CDs and DVDs, water bottles...
Words: 106805 - Pages: 428
...September 2005 Project Portfolio Management at XYZ Pharma Early morning, Monday 29th August 2005. John Smith, head of portfolio management and strategic planning, was paging through the slides he had prepared for the Portfolio Management Board (PMB) meeting which would start at 9 am, and which was scheduled to last until Friday. “We have been preparing this meeting for weeks”, he thought, “and it seems the PMB has some tough decisions to make”. The PMB of XYZ Pharma, the pharmaceutical division of XYZ, one of the world’s leading companies in the life science sector, convenes yearly in August to review the composition of the research and development (R&D) project portfolio. It also meets on a monthly basis to monitor the project portfolio and make decisions regarding new developments. According to John Smith, “The PMB is an important decision making body because it shapes the future of the company by determining its product pipeline”. The PMB members include the CEO of XYZ, the CEO of XYZ Pharma, the heads of the different business units, the heads of Development, Research, Global Marketing and Strategic Planning, the regional heads for the US, Europe and Japan and the functional managers for Regulation, Clinical, Licensing, Technical Research and Development, and Patents. The portfolio group, led by John Smith, had analysed the project portfolio carefully and had highlighted several potential threats that required action. According to John, “There will be an indepth discussion...
Words: 5468 - Pages: 22
...scc SM Supply Chain Operations Reference (SCOR®) model Overview - Version 10.0 supply chain council About Supply Chain Council Supply Chain Council (SCC, supply-chain.org) is a global nonprofit organization whose framework, improvement methodology, and benchmarking tools help member organizations make dramatic and rapid improvements in supply chain performance. SCC established and maintains the supply chain world’s most widely accepted framework for evaluating and comparing supply chain activities and their performance: the Supply Chain Operations Reference (SCOR®) model. The SCOR framework makes it possible for organizations to quickly determine and compare the performance of supply chain and related operations within their organization and against other organizations. SCC and its member volunteers continually advance these tools and provide education on how to leverage them for achieving superior supply chain performance. A consortium of 69 organizations founded SCC in 1996. Today, the SCOR model is used by thousands of organizations worldwide. SCC membership is open to all organizations interested in applying and advancing the state-of-the-art in supply chain management systems and practices. Our members represent a broad cross-section of industries including manufacturers, distributors, retailers, and service providers as well as technology solution providers, business consultants, academic institutions, and government organizations. SCC has chapters in Australia/New...
Words: 9307 - Pages: 38
...products including solid dose forms, Metered Dose Inhalers, Nasal Sprays, Large Volume Intravenous Fluids, Suppositories, and Creams/Ointments. BPL produces and markets 'branded generics' for most diseases ranging from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. The company also manufactures active pharmaceutical ingredients and intravenous fluids and contract manufacture for major international brands of leading multinational companies. BPL utilizes state of the art manufacturing facilities. BPL also has outstanding reverse engineering capabilities. Incorporated in 1976, BPL started off as a distributor of pharmaceutical products. It imported products from global MNCs such as Bayer AG of Germany and Upjohn Inc. of USA and sold them in the local market. It eventually graduated to a manufacturer and distributor of these products in local market under licensing agreements. During the early 80s, BPL launched its own products in the local market. Beximco started its exports operation in the early 90s with APIs. Today BPL is one of the largest exporters of medicines from Bangladesh. BPL employs more than 2,400 staff, including over 300 qualified professionals such as pharmacists, chemists, microbiologists, engineers, doctors etc. BPL is the third largest pharmaceutical manufacturing company in Bangladesh with net sales of BDT 6.87 million, according to the 2013 annual report. 2. Product profiles Beximco Pharma’s...
Words: 1988 - Pages: 8
...Chittagong Stock Exchange on its debut in 1995. Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore In 2005, BPL took over Beximco Infusions Ltd., a listed company of the Beximco Group engaged in manufacturing and marketing of intravenous fluids and got enlisted with the Alternative Investment Market (AIM) of the London Stock Exchange through issuance of Global Depository Receipts (GDRs). Shares of the Company are traded in Dhaka and Chittagong Stock Exchanges of Bangladesh and its GDRs in AIM of the London Stock Exchange. The paper seeks information on the planning and organizing system that used at BPL. Different methods have been employed to analyze the data both from primary and secondary sources. It gives an idea of how information on purchases and sales, both local and foreign are integrated into the data system for evaluation and reporting purposes. Objectives * Introduce Beximco Pharmaceuticals Ltd and its planning and organizing system. * Provide a comprehensive idea on its organizational design in play in different part of the organization * To show the description of the centralization...
Words: 3604 - Pages: 15
...Professor Dr. Durgadas Bhattacherjee Adjunct Professor Department of Business Administration Faculty of Business & Economics Submitted By Md. Amjad Hosen ID: 151-12-596 Semester: Summer 2015 Subject: Strategic Management Program: E.M.B.A Section: ‘B’ DAFFODIL INTERNATIONAL UNIVERSITY Date of Submission: August 09, 2015 Table of Content | Topic Pages 1. Historical Background 2. Company profile 3. Organizational Structure 4. Product Line 5. Market Scenario 6. Business level Strategy Pursued 7. Competitive Advantage 8. SWOT Analysis 9. Possible Measures to Improve Performance 10. Relationship between Business Level Strategy and Performance 11. What I Learned 12. Conclusion Historical Background Beximco Pharma is a leading edge pharmaceutical company and is a member of the Beximco Group, the largest private sector industrial conglomerate in Bangladesh. The firm started operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA and now have grown to become nation's one of the leading pharmaceutical companies, supplying more than 10% of country's total medicine need. Today Beximco Pharma...
Words: 2662 - Pages: 11
...possibilities" 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 0 Business Insights Business Insights is a series of management reports designed to help you make informed, timely business decisions. We understand the problems facing today's managers in taking your business into the next millennium, and appreciate the importance of the role of accurate, up-to-date, incisive market and company analysis. We help you to crystallise your business decision making. Business Insights’ reports are authored by independent experts in their fields and offer results from our unique primary research methodology. Our authors' leading positions allow them to interview key industry executives and to quantify which issues will be of greatest strategic significance in an industry's future. The results of our analysis and recommendations will help you to evaluate the impact of these issues on your business, and plan to position yourselves to take the greatest advantage of opportunities which will arise in tomorrows commercial environment. The strength of our Healthcare research and analysis function is derived from its access to unparalleled databases and libraries of information, its proprietary analytic techniques and its people. Staff are drawn from a very wide set of disciplines including strategic consultancy, medicine, pharmaceutical industry,...
Words: 3014 - Pages: 13
...Internship Report On Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ by Syeda Afrina Sarwar ID: 07304063 BRAC Business School BRAC University, Bangladesh August 2011 ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review Of Costing Function’ Submitted By: Syeda Afrina Sarwar ID: 07304063 BRAC Business School Submitted To: ------------------------------------------------Ms. Rahnuma Ahmed Lecturer BRAC Business School BRAC University, Bangladesh August 2011 Letter of Transmittal August 10, 2011 Ms. Rahnuma Ahmed Lecturer BRAC BUSINESS SCHOOL BRAC University 66, Mohakhali Dhaka-1212 Subject: Submission of Internship Report Dear Madam, I am submitting an internship report titled for ‘Management Accounting Practice At Beximco Pharmaceuticals Ltd: A Review of Costing Function’ as a part of the requirement of the course. Your guideline has been followed in every aspect of preparing this report. I have really enjoyed working on this project and I hope that my work would meet the level of your expectation. Any query on this report is appreciated. Thank You. Sincerely, Syeda Afrina Sarwar ID:07304063 Acknowledgement It’s difficult for me to thank all of those marvelous people who have contributed something of them to this report. There are of course some very special people who cannot go...
Words: 15094 - Pages: 61